[go: up one dir, main page]

NZ325587A - 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity - Google Patents

4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Info

Publication number
NZ325587A
NZ325587A NZ325587A NZ32558796A NZ325587A NZ 325587 A NZ325587 A NZ 325587A NZ 325587 A NZ325587 A NZ 325587A NZ 32558796 A NZ32558796 A NZ 32558796A NZ 325587 A NZ325587 A NZ 325587A
Authority
NZ
New Zealand
Prior art keywords
dihydronaphth
isoxazoles
derivatives
cns activity
cns
Prior art date
Application number
NZ325587A
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NZ325587A publication Critical patent/NZ325587A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NZ325587A 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity NZ325587A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Publications (1)

Publication Number Publication Date
NZ325587A true NZ325587A (en) 1999-02-25

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ325587A NZ325587A (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Country Status (14)

Country Link
EP (1) EP0874833A1 (en)
JP (1) JP3161737B2 (en)
KR (1) KR100308748B1 (en)
CN (1) CN1214046A (en)
AR (1) AR005347A1 (en)
AU (1) AU710059B2 (en)
BR (1) BR9612578A (en)
CA (1) CA2241845C (en)
HU (1) HUP9903706A3 (en)
IL (1) IL125197A0 (en)
NO (1) NO983100L (en)
NZ (1) NZ325587A (en)
WO (1) WO1997025317A1 (en)
ZA (1) ZA9725B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8656101A (en) * 2000-08-21 2002-03-04 Univ Georgetown 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
JP4580653B2 (en) * 2002-04-02 2010-11-17 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Substituted aminoisoxazoline derivatives and their use as antidepressants
TW200409777A (en) * 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
CN100522972C (en) * 2002-08-15 2009-08-05 詹森药业有限公司 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
CA2495058C (en) * 2002-08-21 2012-01-03 Janssen Pharmaceutica N.V. C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
EP2597089A1 (en) 2009-10-29 2013-05-29 Bristol-Myers Squibb Company Tricyclic heterocyclic compounds
WO2018045149A1 (en) 2016-09-02 2018-03-08 Bristol-Myers Squibb Company Substituted tricyclic heterocyclic compounds
US11059784B2 (en) 2017-08-09 2021-07-13 Bristol-Myers Squibb Company Oxime ether compounds
US11046646B2 (en) 2017-08-09 2021-06-29 Bristol-Myers Squibb Company Alkylphenyl compounds
KR102002633B1 (en) 2018-07-19 2019-07-22 김태효 Non slip foot wear with separating cushion part
KR102429797B1 (en) 2019-12-31 2022-08-05 주식회사 제이패션 Functional non-sewn overshoes and manufacturing method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
ES2076253T3 (en) * 1989-05-19 1995-11-01 Hoechst Roussel Pharma N- (ARYLOXYALKYL) -HETEROARILPIPERIDINES AND -HETEROARILPIPERAZINAS, A PROCEDURE FOR ITS PREPARATION AND USE AS MEDICINES.
JPH08502958A (en) * 1992-10-23 1996-04-02 メルク シヤープ エンド ドーム リミテツド Dopamine receptor subtype ligand

Also Published As

Publication number Publication date
CN1214046A (en) 1999-04-14
BR9612578A (en) 1999-07-27
AR005347A1 (en) 1999-04-28
ZA9725B (en) 1997-07-07
HUP9903706A3 (en) 2000-09-28
WO1997025317A1 (en) 1997-07-17
AU1412697A (en) 1997-08-01
IL125197A0 (en) 1999-03-12
HUP9903706A2 (en) 2000-08-28
CA2241845C (en) 2002-10-01
KR100308748B1 (en) 2001-12-12
KR19990077033A (en) 1999-10-25
CA2241845A1 (en) 1997-07-17
NO983100D0 (en) 1998-07-03
JP3161737B2 (en) 2001-04-25
JPH11510816A (en) 1999-09-21
NO983100L (en) 1998-09-04
AU710059B2 (en) 1999-09-09
EP0874833A1 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
GB2319250B (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
NZ329176A (en) 2,5-dioxo-imidazolidine derivatives and medicaments
EP0894807A4 (en) GPIb-LIPID COMPLEX AND USES THEREOF
IL121298A0 (en) N-(4-aryl-thiazol-2-YL)-sulphonamide derivatives and their uses
PL329121A1 (en) Substituted derivatives of 1,2,3,4-tetrahydronaphtalene
IL111223A (en) 3-phenylmethanoyl benzo [b] thiene derivatives and uses thereof
IL126968A0 (en) Alkylaminobenzothiazole and benzoxazole derivatives
HUP9904032A3 (en) 1,2,4-benzothiadiazine derivatives,their preparation and use
PL348668A1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
NZ325587A (en) 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity
HUP9902901A3 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofuranamines and 2-aminocyclohepta[b]benzofurans
HK1023124A1 (en) Oxime derivatives and their use as fungicides
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
HU9700609D0 (en) 1,25-dihydroxy-12,22,23-trisdehydro-cholecalciferol derivatives
PL315809A1 (en) Derivatives of 1,3,2-benzothiazole monoxide
GB9417969D0 (en) Alkaloids and derivatives thereof
IL120285A (en) Process for the preparation of 1,5-benzothiazepine derivatives, process for the preparation of the intermediate thereof and an intermediate thereof
IL113150A0 (en) 1,2,4-triazolo [4,3-a]pyrazin-4-one derivatives and preparation thereof
PL301984A1 (en) Derivatives of 3-phenyl-5-methylisoxzaole and 4,5-dihydroisoxasole
IL129029A0 (en) 8(9)-Dehydroestradiol derivatives
PL332044A1 (en) 25-methylene and 24,25-epoxy marcphortines and paraherquamides
HUP9803035A3 (en) 7-bromo- and 7,7-dibromo-cepham and cephem derivatives
IL117864A0 (en) Benzamidoxime derivatives their preparation and use
IL130921A0 (en) Tetrahydroisoindole and hexahydroisoindole derivatives
GB9421887D0 (en) Benzodioxanylimidazoline and bensodioxanyllimidazole derivatives